Status:

COMPLETED

Research Study Examining Nerve Block for Migraine

Lead Sponsor:

Thomas Jefferson University

Conditions:

Migraine

Eligibility:

All Genders

18-80 years

Brief Summary

Migraine and the skin sensitivity that accompanies it can go away in minutes after a nerve block, which is a procedure involving an injection of a small amount of a local anesthetic next to a nerve to...

Eligibility Criteria

Inclusion

  • Subjects with episodic or transformed migraine age 18to 80 years old.
  • Subjects must have unilateral migraine headache and trigeminal distribution brush allodynia at the time of injection.
  • Subjects must be able to consent or assent to the study.

Exclusion

  • Subjects who in their own or in the investigator's opinion are unable to report the severity of four symptoms (pin sharpness to determine efficacy of nerve block, headache severity, photophobia severity and allodynia severity), every 30 seconds for 5 minutes post injection;
  • Subjects with skull defect, or history of injury to the area of the GON.
  • Subjects with prior adverse reaction to GON block, lidocaine or marcaine.
  • Subjects who are pregnant or lactating

Key Trial Info

Start Date :

June 1 2005

Trial Type :

OBSERVATIONAL

End Date :

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00203346

Start Date

June 1 2005

Last Update

January 23 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jefferson Headache Center

Philadelphia, Pennsylvania, United States, 19107